A specific gene variant called SLC19A1 A80G is associated with a modestly increased risk of Down syndrome in babies, according to a 2026 meta-analysis of 16 studies involving 4,708 mothers. Mothers carrying two copies of the G version of this gene had a 29 to 47 percent higher risk compared to those without the variant, though most mothers with this variant still have unaffected children. The variant affects how cells process folate, a B vitamin essential for healthy cell division.
Researchers analyzed 16 studies involving nearly 4,000 mothers to understand how a specific gene variant affects the risk of having a child with Down syndrome. The gene variant, called SLC19A1 A80G, affects how the body processes folate, a B vitamin crucial for healthy cell division. According to Gram Research analysis, mothers who carry two copies of a particular version of this gene had about a 29 to 47 percent higher risk of having a child with Down syndrome compared to mothers without this variant. While the increased risk is real, it remains relatively small, and most mothers with this gene variant have children without Down syndrome.
Key Statistics
A 2026 meta-analysis of 16 studies involving 1,958 mothers with Down syndrome children and 2,750 control mothers found that mothers with two copies of the G variant in the SLC19A1 A80G gene had a 29 percent higher risk of having a child with Down syndrome.
Among the highest-quality studies in the meta-analysis, mothers homozygous for the G allele showed a 47 percent increased risk of Down syndrome compared to mothers with the AA genotype.
The 2026 meta-analysis found that mothers carrying even one copy of the G allele had a 21 percent increased risk of having a child with Down syndrome compared to mothers with only A alleles.
Trial sequential analysis confirmed that the 16 studies included in the meta-analysis provided sufficient data to support the observed associations between the SLC19A1 A80G polymorphism and Down syndrome risk.
The Quick Take
- What they studied: Whether a specific genetic variation in the folate carrier gene increases a mother’s chances of having a baby with Down syndrome
- Who participated: 16 different research studies combined, including 1,958 mothers who had children with Down syndrome and 2,750 mothers who did not
- Key finding: Mothers carrying two copies of the G version of the gene had a 29 to 47 percent higher risk of having a child with Down syndrome, depending on how researchers analyzed the data
- What it means for you: If you carry this gene variant, your risk increases, but it remains relatively low. Genetic counseling and ensuring adequate folate intake may be helpful, but this single gene is just one of many factors involved in Down syndrome risk
The Research Details
This is a meta-analysis, which means researchers combined results from 16 separate studies to get a bigger, more reliable picture. Each of the original studies compared mothers who had children with Down syndrome to mothers who did not, and looked at whether they carried a specific gene variant called SLC19A1 A80G. The researchers used statistical methods to combine all these studies together and see if a pattern emerged. They also performed additional analysis called trial sequential analysis to make sure their findings were strong enough to trust.
Down syndrome happens when cells have an extra copy of chromosome 21. Scientists have long suspected that problems with folate metabolism, the process of how your body uses the B vitamin folate, might play a role. The SLC19A1 gene controls a protein that carries folate into cells. If this gene has a variant that makes it work less efficiently, cells might not get enough folate, which could increase the risk of chromosome problems during egg formation. By combining many studies, researchers can see if this theory holds up in real people.
This meta-analysis is fairly strong because it included 16 studies with a total of nearly 4,700 mothers. The researchers checked that the studies they included were well-designed case-control studies, which is a reliable research method. They also performed trial sequential analysis, a special statistical test that confirms whether they had enough data to trust their conclusions. However, the studies came from different countries and populations, which means results might vary depending on genetics and environment.
What the Results Show
When researchers looked at mothers who carried two copies of the G version of the gene (called the GG genotype), they found these mothers had a 29 percent higher risk of having a child with Down syndrome compared to mothers with the AA genotype. When they looked at only the highest-quality studies, this risk increased to 47 percent. The researchers also found that mothers with even one copy of the G version had a 21 percent higher risk compared to mothers with only A versions. These increases are real and statistically significant, meaning they are unlikely to be due to chance. However, it is important to remember that even with this increased risk, most mothers with this gene variant do not have children with Down syndrome.
The researchers also compared mothers with two G copies directly to mothers with two A copies, and found a 47 percent increased risk. When they looked at the G allele (the specific version of the gene) compared to the A allele across all mothers, they found a 21 percent increased risk. These findings were consistent across multiple ways of analyzing the data, which suggests the results are reliable.
This meta-analysis confirms what smaller individual studies have suggested: that folate metabolism problems may contribute to Down syndrome risk. The findings support the theory that the SLC19A1 gene variant affects how efficiently cells take up folate, which is essential for proper chromosome separation during egg formation. However, this is just one piece of a much larger puzzle, as Down syndrome risk involves many genetic and environmental factors.
The studies included came from different countries and populations, so the results might not apply equally to all ethnic groups. Some studies had small numbers of participants, which can make results less reliable. The researchers could not look at other important factors like maternal age, folate intake, or other genetic variants that might also affect risk. Additionally, this gene variant explains only a small part of Down syndrome risk, so many other unknown factors are likely involved.
The Bottom Line
If you are planning pregnancy and have family history of Down syndrome or genetic concerns, consider genetic counseling to understand your personal risk factors. Ensure adequate folate intake through diet or supplements, as recommended by your healthcare provider. This is especially important if you carry this gene variant, as your body may need more folate to work properly. Standard prenatal screening tests remain important for all pregnancies. Confidence level: Moderate, based on combined evidence from multiple studies, though this single gene is just one of many factors.
Women planning pregnancy, especially those with family history of Down syndrome or known carriers of this gene variant. Healthcare providers and genetic counselors should be aware of this association when assessing Down syndrome risk. This finding is less relevant for men, as the association is specific to maternal genetics during egg formation.
This gene variant does not cause immediate changes. Its effect occurs during pregnancy when eggs are developing. If you are concerned about this variant, genetic testing and counseling should happen before or early in pregnancy planning. Increasing folate intake can begin immediately and should continue throughout pregnancy.
Frequently Asked Questions
Does having the SLC19A1 A80G gene variant mean my baby will have Down syndrome?
No. This gene variant increases risk slightly, but most mothers with it have babies without Down syndrome. The variant is just one of many factors involved. Genetic counseling can help you understand your individual risk based on all factors.
Can I reduce my Down syndrome risk if I carry this gene variant?
Ensuring adequate folate intake through diet or supplements may help, since this gene affects folate processing. Prenatal screening tests remain important for all pregnancies. Discuss your specific situation with a genetic counselor or healthcare provider.
How common is the SLC19A1 A80G gene variant?
The meta-analysis does not specify overall population frequency, but the variant is common enough that researchers found nearly 4,700 mothers to study. Frequency varies by ethnic background and geographic region.
Should I get genetic testing for this gene variant before pregnancy?
If you have family history of Down syndrome or genetic concerns, genetic counseling before pregnancy can help determine if testing is appropriate for you. Your healthcare provider can discuss whether this test would be useful for your situation.
What is folate and why does it matter for this gene variant?
Folate is a B vitamin essential for cell division and chromosome separation. The SLC19A1 gene controls how cells absorb folate. If the gene variant reduces folate uptake, cells may not divide properly, potentially increasing Down syndrome risk. Adequate folate intake is important.
Want to Apply This Research?
- Track daily folate intake in micrograms, aiming for 400 to 800 micrograms daily if planning pregnancy or pregnant. Log sources including leafy greens, legumes, fortified grains, and supplements.
- If you carry this gene variant, set a daily reminder to take a prenatal vitamin with folate and eat one folate-rich food at each meal. Use the app to log these actions and monitor consistency over time.
- Create a monthly report showing folate intake trends and consistency with supplementation. If planning pregnancy, share this data with your healthcare provider to ensure adequate folate status before conception.
This research identifies an association between a gene variant and Down syndrome risk, but does not prove the variant causes Down syndrome. This gene variant is just one of many factors affecting risk. Genetic testing, counseling, and medical decisions should only be made in consultation with qualified healthcare providers or genetic counselors. Prenatal screening and diagnostic tests remain the standard of care for assessing Down syndrome risk during pregnancy. This information is for educational purposes and should not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.